4d
Pharmaceutical Technology on MSNPharma industry dodges tariff blow but still braces for disruptionAccording to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.
The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...
The Trump administration carved out an exception for pharmaceuticals from the president's new tariff regime, at least for now ...
Two European-headquartered drugmakers told Reuters this week they are sending as much of their medicines across the Atlantic ...
Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...
Big pharmaceutical stocks mostly rose after President Trump’s executive order exempted medicines from new tariffs. Merck, ...
The U.S. pharmaceutical industry is bracing for a possible wave of tariffs on foreign-made drugs, even as they received a short-term exemption this week under President Donald Trump’s sweeping new ...
2d
24/7 Wall St. on MSN4 Blue Chip Pharmaceutical High-Yield Dividend Stocks Are Tariff WinnersLarge-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.
European Commission President Ursula von der Leyen held a call with metals industry representatives on Monday and was due to ...
8h
Daily Post Nigeria on MSNEU discusses US tariff response with auto, steel, pharma executivesThe President of the European Commission, Ursula von der Leyen, on Monday held a call with metals industry representatives ...
Trump announced a 10% tariff on all U.S. trading partners, in addition to higher reciprocal tariffs on the EU and China. But ...
Drugmakers are pushing back against pharmaceutical tariffs. Some companies are lobbying the Trump administration to phase in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results